P

Psyence Biomedical Ltd
NASDAQ:PBM

Watchlist Manager
Psyence Biomedical Ltd
NASDAQ:PBM
Watchlist
Price: 0.871 USD 30% Market Closed
Market Cap: 1.6m USD

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
$0
/
$0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Operating
Margin
CA
Psyence Biomedical Ltd
NASDAQ:PBM
1.6m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.2B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
CH
Novartis AG
SIX:NOVN
219.6B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
No Stocks Found

Market Distribution

Not Available
No Country distribution data available for this multiple

Psyence Biomedical Ltd
Glance View

Market Cap
1.6m USD
Industry
N/A

Psyence Biomedical Ltd is a CA-based company operating in industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.

PBM Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top